Search details
1.
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-ß2 levels in metastatic colorectal cancer patients (Alliance).
BMC Genomics
; 25(1): 473, 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38745123
2.
Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).
Pharmacogenomics J
; 24(2): 6, 2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-38438359
3.
Current issues in dose-finding designs: A response to the US Food and Drug Adminstration's Oncology Center of Excellence Project Optimus.
Clin Trials
; 21(3): 267-272, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38570906
4.
Quality of life outcomes for patients with metastatic castration-resistant prostate cancer and pretreatment prognostic score.
Prostate
; 83(7): 688-694, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36842158
5.
American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine.
CA Cancer J Clin
; 66(5): 370-4, 2016 09.
Article
in English
| MEDLINE | ID: mdl-26784705
6.
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
JAMA
; 330(4): 328-339, 2023 07 25.
Article
in English
| MEDLINE | ID: mdl-37428480
7.
Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
Prostate
; 82(7): 858-866, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35286730
8.
Penalized weighted proportional hazards model for robust variable selection and outlier detection.
Stat Med
; 41(17): 3398-3420, 2022 07 30.
Article
in English
| MEDLINE | ID: mdl-35581736
9.
Landscape of coronavirus disease 2019 clinical trials: New frontiers and challenges.
Clin Trials
; 19(5): 561-572, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35786000
10.
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis.
Lancet Oncol
; 22(3): 402-410, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33662287
11.
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
Cancer
; 127(16): 2954-2965, 2021 08 15.
Article
in English
| MEDLINE | ID: mdl-33951180
12.
Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer.
J Urol
; 206(2): 298-307, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33818140
13.
On the design and the analysis of stratified biomarker trials in the presence of measurement error.
Stat Med
; 40(12): 2783-2799, 2021 05 30.
Article
in English
| MEDLINE | ID: mdl-33724513
14.
A semiparametric modeling approach for analyzing clinical biomarkers restricted to limits of detection.
Pharm Stat
; 20(6): 1061-1073, 2021 11.
Article
in English
| MEDLINE | ID: mdl-33855778
15.
Estimand framework: Are we asking the right questions? A case study in the solid tumor setting.
Pharm Stat
; 20(2): 324-334, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33155417
16.
Discordant and heterogeneous clinically relevant genomic alterations in circulating tumor cells vs plasma DNA from men with metastatic castration resistant prostate cancer.
Genes Chromosomes Cancer
; 59(4): 225-239, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31705765
17.
The Lancet Commission on prostate cancer: planning for the surge in cases.
Lancet
; 403(10437): 1683-1722, 2024 Apr 27.
Article
in English
| MEDLINE | ID: mdl-38583453
18.
Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs.
Oncologist
; 25(3): e405-e411, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32162805
19.
Score and deviance residuals based on the full likelihood approach in survival analysis.
Pharm Stat
; 19(6): 940-954, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32776412
20.
Group-sequential logrank methods for trial designs using bivariate non-competing event-time outcomes.
Lifetime Data Anal
; 26(2): 266-291, 2020 04.
Article
in English
| MEDLINE | ID: mdl-30980317